Evidence mapPaperPMID 28242049Full record

ReviewAtherosclerosis2017

High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis.

Scott M Gordon, Alan T Remaley

Open access · greenAbstract readReview
In one paragraph

Review in Atherosclerosis, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. The HDL Proteome Watch: Compilation of studies leads to new insights on HDL function.Biochimica et biophysica acta. Molecular and cell biology of lipids · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Scott M GordonLipoprotein Metabolism Section, National Heart, Lung, and Blood Institute, Bethesda, MD, USA. Electronic address: scott.gordon@nih.gov.
Alan T RemaleyLipoprotein Metabolism Section, National Heart, Lung, and Blood Institute, Bethesda, MD, USA.
National Heart Lung and Blood Institute · US

Funding

Development of Apo Mimetic Peptides for the Treatment Cardiovascular DiseaseZIAHL006095 · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · 2025 to 2025
$1.6M
Method Development: Lipoprotein fraction analysisZ01CL010303 · CLINICAL CENTER · 1999 to 2003
Intramural NIH HHS Z01 CL010303Intramural NIH HHS Z99 HL999999
6 · The paper itself

Abstract

High density lipoproteins (HDL) represent a compositionally diverse population of particles in the circulation, containing a wide variety of lipids and proteins. Gene ontology functional analysis of the 96 commonly identified HDL binding proteins reveals that almost half of these proteins are either proteases or have known roles in protease regulation. Here, we discuss the activities of some of these proteins in regard to their roles in regulating proteases involved in inflammation, coagulation, and complement activation, particularly in the context of atherosclerosis. The overall goal of this review is to discuss potential functional roles of HDL in protease regulatory pathways based on current literature and known functions of HDL binding proteins and to promote the consideration of HDL as a global modulator of proteolytic equilibrium.

Indexed as

Blood CoagulationComplement ActivationAnimalsAtherosclerosisHumansInflammationLipoproteins, HDLPeptide HydrolasesSignal TransductionThrombosisLipoproteins, HDLPeptide HydrolasesCoagulationComplement systemHigh density lipoproteinInflammationProteaseProtease inhibitorSERPIN

Identifiers

PMID28242049
PMCPMC5391047
OpenAlexW2551668921

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.